Switch from Enfuvirtide to Raltegravir Lowers Plasma Concentrations of Darunavir and Tipranavir: a Pharmacokinetic Substudy of the EASIER-ANRS 138 Trial

We compared tipranavir and darunavir concentrations measured at steady state in 20 human immunodeficiency virus (HIV)-infected patients enrolled in the EASIER-ANRS 138 clinical trial who switched from enfuvirtide to raltegravir while maintaining the same background regimen. The geometric mean ratios...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Goldwirt, Lauriane, Braun, Joséphine, de Castro, Nathalie, Charreau, Isabelle, Barrail-Tran, Aurélie, Delaugerre, Constance, Raffi, François, Lascoux-Combe, Caroline, Aboulker, Jean-Pierre, Taburet, Anne-Marie, Molina, Jean-Michel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2011
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122468/
https://ncbi.nlm.nih.gov/pubmed/21576452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01827-10
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller